Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study
Jonathan M. Schott(UK Dementia Research Institute), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), Fowzia Ibrahim(King's College London), Adam Waldman(Royal Society of Edinburgh), Chris Frost(Eli Lilly (United States)), David MacManus(NIHR Queen Square Dementia Biomedical Research Unit)
Cited by 59
Related Papers
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
|Nature Genetics|2019|3.3k
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
|Nature Genetics|2011|2.1k